Genetic counseling in melanoma

被引:24
作者
Badenas, Celia [1 ,3 ]
Aguilera, Paula [2 ,3 ,4 ]
Puig-Butille, Joan A. [3 ]
Carrera, Cristina [2 ,3 ,4 ]
Malvehy, Josep [2 ,3 ,4 ]
Puig, Susana [2 ,3 ,4 ]
机构
[1] Hosp Clin Barcelona, Melanoma Unit, Biochem & Mol Genet Serv, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Melanoma Unit, Dept Dermatol, E-08036 Barcelona, Spain
[3] CIBERER, Barcelona, Spain
[4] IDIBAPS, Barcelona, Spain
关键词
gene; genetic counseling; melanoma; mutation; predisposition; MELANOCORTIN; 1; RECEPTOR; HIGH-RISK; CUTANEOUS MELANOMA; CDKN2A MUTATIONS; FOLLOW-UP; VARIANT; MC1R; INHIBITION; FAMILIES; CANCER;
D O I
10.1111/j.1529-8019.2012.01499.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Genetic counseling may be offered to families with melanoma and to individuals with multiple melanomas to better understand the genetic susceptibility of the disease, the influence of environmental factors, the inheritance of the risk, and behavior that decreases the risk of dying from melanoma, including specific dermatological follow-up such as total body photography and digital dermoscopy. Genetic testing may be offered to those individuals with more than a 10% chance of being a carrier of a mutation. This risk varies according to the incidence of melanoma in the country and sun behavior. In countries with a low-medium incidence of melanoma, genetic testing should be offered to families with two cases of melanoma or an individual with two primary melanomas. In countries with a high incidence, families with three cases of melanoma, with two melanomas and one pancreatic adenocarcinoma, or patients with three primary melanomas, may benefit from genetic testing.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 46 条
  • [1] ANDERSON DE, 1991, ANTICANCER RES, V11, P433
  • [2] CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families
    Aspinwall, Lisa G.
    Leaf, Samantha L.
    Dola, Erin R.
    Kohlmann, Wendy
    Leachman, Sancy A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (06) : 1510 - 1519
  • [3] The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil
    Bakos, Renato M.
    Besch, Robert
    Zoratto, Gabriela G.
    Godinho, Janaina M.
    Mazzotti, Nicolle G.
    Ruzicka, Thomas
    Bakos, Lucio
    Santos, Sidney E.
    Ashton-Prolla, Patricia
    Berking, Carola
    Giugliani, Roberto
    [J]. EXPERIMENTAL DERMATOLOGY, 2011, 20 (11) : 890 - 893
  • [4] DNA damage signalling guards against activated oncogenes and tumour progression
    Bartek, J.
    Bartkova, J.
    Lukas, J.
    [J]. ONCOGENE, 2007, 26 (56) : 7773 - 7779
  • [5] Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
    Begg, CB
    Orlow, I
    Hummer, AJ
    Armstrong, BK
    Kricker, A
    Marrett, LD
    Millikan, RC
    Gruber, SB
    Anton-Culver, H
    Zanetti, R
    Gallagher, RP
    Dwyer, T
    Rebbeck, TR
    Mitra, N
    Busam, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20): : 1507 - 1515
  • [6] A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
    Bertolotto, Corine
    Lesueur, Fabienne
    Giuliano, Sandy
    Strub, Thomas
    de Lichy, Mahaut
    Bille, Karine
    Dessen, Philippe
    d'Hayer, Benoit
    Mohamdi, Hamida
    Remenieras, Audrey
    Maubec, Eve
    de la Fouchardiere, Arnaud
    Molinie, Vincent
    Vabres, Pierre
    Dalle, Stephane
    Poulalhon, Nicolas
    Martin-Denavit, Tanguy
    Thomas, Luc
    Andry-Benzaquen, Pascale
    Dupin, Nicolas
    Boitier, Francoise
    Rossi, Annick
    Perrot, Jean-Luc
    Labeille, Bruno
    Robert, Caroline
    Escudier, Bernard
    Caron, Olivier
    Brugieres, Laurence
    Saule, Simon
    Gardie, Betty
    Gad, Sophie
    Richard, Stephane
    Couturier, Jerome
    Teh, Bin Tean
    Ghiorzo, Paola
    Pastorino, Lorenza
    Puig, Susana
    Badenas, Celia
    Olsson, Hakan
    Ingvar, Christian
    Rouleau, Etienne
    Lidereau, Rosette
    Bahadoran, Philippe
    Vielh, Philippe
    Corda, Eve
    Blanche, Helene
    Zelenika, Diana
    Galan, Pilar
    Chaudru, Valerie
    Lenoir, Gilbert M.
    [J]. NATURE, 2011, 480 (7375) : 94 - U259
  • [7] An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele
    Bertram, CG
    Gaut, RM
    Barrett, JH
    Pinney, E
    Whitaker, L
    Turner, F
    Bataille, V
    Silvaj, ID
    Swerdlow, AJ
    Bishop, DT
    Bishop, JAN
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (04) : 961 - 965
  • [8] Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894
  • [9] MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations
    Box, NF
    Duffy, DL
    Chen, W
    Stark, M
    Martin, NG
    Sturm, RA
    Hayward, NK
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 765 - 773
  • [10] Bradford PT, 2010, ARCH DERMATOL, V146, P265, DOI 10.1001/archdermatol.2010.2